David Platt's Net Worth
$10.1 Million
Who is David Platt?
David Platt has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include Boston Therapeutics, Inc., BIOXYTRAN, INC, PRO PHARMACEUTICALS INC, and GLYCOGENESYS INC.
SEC CIK
David Platt's CIK is 0001166440
Past Insider Trading and Trends
2015 was David Platt's most active year for acquiring shares with 26 total transactions. David Platt's most active month to acquire stocks was the month of December. 2003 was David Platt's most active year for disposing of shares, totalling 25 transactions. David Platt's most active month to dispose stocks was the month of July. 2023 saw David Platt paying a total of $3,110,679.88 for 13,088,303 shares, this is the most they've acquired in one year. In 2021 David Platt cashed out on 3,201,788 shares for a total of $441,846.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Boston Therapeutics, Inc. No price found
CEO and Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.08% | 6K |
$0.12 | $747.60 | 7.56M |
May 14 - May 15
| |||
Form 4
| +0.13% | 10K |
$0.22 | $2,188.40 | 7.56M |
Mar 9
| |||
Form 4
| +0.00% | 250 |
$0.58 | $145.00 | 7.55M |
Feb 17
| |||
Form 4
| +0.00% | 250 |
$0.51 | $127.50 | 7.55M |
Feb 12
| |||
Form 4
| +0.01% | 600 |
$0.43 | $259.60 | 7.55M |
Feb 2 - Feb 4
| |||
Form 4
| +0.01% | 800 |
$0.45 | $359.78 | 7.54M |
Jan 27 - Jan 28
| |||
Form 4
| +0.01% | 500 |
$0.40 | $200.00 | 7.54M |
Jan 23
| |||
Form 4
| +0.04% | 3K |
$0.34 | $1,020.00 | 7.54M |
Jan 20
| |||
Form 4/A
| +0.01% | 600 |
$0.60 | $359.94 | 7.54M |
Jan 15 - Jan 16
| |||
Form 4
| +0.01% | 1K |
$0.60 | $599.90 | 7.54M |
Jan 15 - Jan 16
| |||
Form 4
| +0.02% | 1.5K |
$0.63 | $939.25 | 7.54M |
Jan 9 - Jan 12
| |||
Form 4
| +0.01% | 700 |
$0.65 | $455.33 | 7.54M |
Jan 7 - Jan 8
| |||
Form 4
| -0.00% | -100.00 |
$0.60 | -$59.99 | 7.54M |
Jan 5
| |||
Form 4
| -0.01% | -1.10K |
$0.65 | -$712.80 | 7.54M |
Dec 31 - Jan 2
| |||
Form 4
| -0.04% | -3.00K |
$0.64 | -$1,918.60 | 7.54M |
Dec 30 - Dec 31
| |||
Form 4
| -3.83% | -300.00K |
—
|
—
| 7.53M |
Feb 12 - Mar 5
| |||
Form 4
| +0.01% | 1.99K |
$0.90 | $1,774.35 | 16.17M |
Jun 8 - Jun 11
| |||
Form 4
| -1.94% | -160.00K |
$0.25 | -$40,000.00 | 8.08M |
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOXYTRAN, INC (BIXT) Snapshot price: $0.10295
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.23% | 439.6K |
$0.10 | $45,717.88 | 20.13M |
Mar 27
| |||
Form 4
| +22.36% | 3.6M |
$0.14 | $485,904.02 | 19.69M |
Jan 16
| |||
Form 4
| +56.72% | 5.82M |
$0.14 | $786,340.04 | 16.09M |
Sep 14
| |||
Form 4
| +5.12% | 500K |
$0.32 | $160,000.00 | 10.27M |
Aug 21
| |||
Form 4
| -0.47% | -92.00K |
$0.32 | -$29,440.00 | 19.54M |
May 17
| |||
Form 4
| +165.05% | 6.76M |
$0.32 | $2,164,339.84 | 10.86M |
Apr 14
| |||
Form 4
| -15.77% | -411.30K |
—
| -$1,233.90 | 2.2M |
Nov 21
| |||
Form 4
| +1.00% | 455.67K |
—
| $455.67 | 45.96M |
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| -2.45% | -1.13M |
$0.14 | -$437,709.61 | 45.1M |
May 2 - Dec 3
| |||
Form 4
| +6.88% | 2.97M |
$0.13 | $386,618.44 | 46.23M |
Jun 4
| |||
Form 4
| +0.53% | 227.8K |
$0.24 | $54,672.00 | 43.26M |
Jan 15
| |||
Form 4
| -1.97% | -864.70K |
—
| -$864.70 | 43.03M |
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PRO PHARMACEUTICALS INC (GALT) Snapshot price: $1.69
Chairman & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 11.67K |
—
|
—
| 11.67K |
Apr 1 - Oct 8
| |||
Form 4/A
|
∞
| 26.3K |
$0.20 | $5,260.00 | 26.3K |
Sep 18
| |||
Form 4
|
∞
| 1K |
$0.23 | $230.00 | 1K |
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| -100.00% | -4.40K |
$3.75 | -$16,500.00 |
0
|
Scheduled
|
Jun 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
| No matching records found | |||||||||
GLYCOGENESYS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.26% | -1.32M |
$0.74 | -$992,995.50 | 12.89M |
Aug 12 - Aug 27
| |||
Form 4
| -2.39% | -44.30K |
$0.51 | -$22,593.00 | 1.81M |
Aug 7
| |||
Form 4
| -0.61% | -11.10K |
$0.54 | -$5,994.00 | 1.8M |
Aug 6
| |||
Form 4
| -0.59% | -10.70K |
$0.49 | -$5,243.00 | 1.8M |
Aug 8
| |||
Form 4
| -1.52% | -27.30K |
$0.49 | -$13,377.00 | 1.77M |
Aug 11
| |||
Form 4
| -1.41% | -30.44K |
$0.90 | -$27,392.40 | 2.13M |
Jul 9
| |||
Form 4
| -2.16% | -45.70K |
$0.88 | -$40,216.00 | 2.07M |
Jul 14
| |||
Form 4
| -1.21% | -25.00K |
$0.88 | -$22,000.00 | 2.04M |
Jul 15
| |||
Form 4
| -2.21% | -45.10K |
$0.83 | -$37,433.00 | 2M |
Jul 16
| |||
Form 4
| -0.95% | -19.00K |
$0.82 | -$15,580.00 | 1.98M |
Jul 16
| |||
Form 4
| -1.01% | -20.00K |
$0.81 | -$16,200.00 | 1.96M |
Jul 18
| |||
Form 4
| -2.04% | -40.00K |
$0.77 | -$30,800.00 | 1.92M |
Jul 21
| |||
Form 4
| -1.08% | -20.70K |
$0.73 | -$15,111.00 | 1.9M |
Jul 22
| |||
Form 4
| -1.58% | -30.00K |
$0.67 | -$20,100.00 | 1.87M |
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||